Benjamin Edwards Inc Novartis Ag Transaction History

Benjamin Edwards Inc

$520 Million
Q2 2024

A detailed history of Benjamin Edwards Inc transactions in Novartis Ag stock. As of the latest transaction made, Benjamin Edwards Inc holds 23,930 shares of NVS stock, worth $2.72 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

23,930

Previous 23,736 0.82%

Holding current value

$2.72 Million

Previous $2.3 Million 10.98%

% of portfolio

0.49%

Previous 0.46%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $17,958 - $20,829	194 Added 0.82%	23,930 $2.55 Million
Q1 2024 Apr 29, 2024	BUY	$95.27 - $108.47 $64,974 - $73,976	682 Added 2.96%	23,736 $2.3 Million
Q4 2023 Feb 06, 2024	SELL	$92.27 - $101.54 $374,062 - $411,643	-4,054 Reduced 14.95%	23,054 $2.33 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $315,829 - $350,503	3,334 Added 14.02%	27,108 $2.76 Million
Q2 2023 Aug 15, 2023	BUY	$92.52 - $104.91 $345,099 - $391,314	3,730 Added 18.61%	23,774 $2.4 Million
Q1 2023 Apr 27, 2023	BUY	$80.03 - $92.81 $158,619 - $183,949	1,982 Added 10.97%	20,044 $1.84 Million
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $168,627 - $206,504	2,232 Added 14.1%	18,062 $1.64 Million
Q3 2022 Oct 28, 2022	SELL	$74.61 - $87.26 $67,820 - $79,319	-909 Reduced 5.43%	15,830 $1.2 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $36,636 - $42,656	-455 Reduced 2.65%	16,739 $1.42 Million
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $445,491 - $503,937	5,561 Added 47.8%	17,194 $1.51 Million
Q4 2021 Feb 07, 2022	BUY	$79.7 - $88.13 $886,742 - $980,534	11,126 Added 2194.48%	11,633 $1.02 Million
Q3 2021 Nov 02, 2021	BUY	$81.78 - $95.14 $25,106 - $29,207	307 Added 153.5%	507 $41,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $15,063 - $17,230	200 New	200 $19,000

Others Institutions Holding NVS

# of Institutions

1,425

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $245B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Novartis Ag Transaction History